Introduction

Ulcerative colitis (UC) is a chronic inflammatory bowel disease in which inflammation develops in the lining of the large intestine, usually beginning in the rectum and extending upward through part or all of the colon. The disease commonly follows a relapsing pattern, meaning that symptoms may become active during a flare and improve during remission.

Clinical disease activity refers to how active and severe the disease is at a particular time. Doctors do not determine disease activity from symptoms alone. They combine the patient's symptoms, physical examination, blood and stool tests, endoscopic findings, and validated disease-activity scores to obtain a more complete picture. Clinical indices are useful for standardizing assessment and monitoring changes over time.

The assessment of disease activity is important because a patient may feel better while inflammation is still present in the intestine. Conversely, symptoms such as abdominal discomfort or altered bowel habits may sometimes occur without significant active inflammation. Therefore, modern UC management increasingly combines clinical assessment with objective measurements.

What Does Clinical Disease Activity Mean?

Clinical disease activity in ulcerative colitis (UC) refers to the current level of symptoms and inflammatory activity caused by the disease. It helps clinicians determine whether ulcerative colitis is currently active, improving with treatment, stable, or becoming more severe. Importantly, disease activity should not be judged from a single symptom or test; clinical symptoms, laboratory markers, endoscopy, and the patient's overall condition are considered together.

What doctors assess

Stool frequency: Doctors ask how many bowel movements occur each day and whether this has increased from the patient's normal pattern. Increased frequency can indicate active intestinal inflammation.

Rectal bleeding: Blood mixed with stool, blood coating the stool, or frequent visible bleeding is an important sign of active UC. The amount and frequency of bleeding help determine disease activity.

Bowel urgency: Patients may experience a sudden, difficult-to-delay need to pass stool. Severe urgency can interfere with work, travel, sleep, and everyday activities.

Abdominal pain or cramps: Abdominal pain, cramping, or discomfort may occur when ulcerative colitis inflammation is active. However, pain by itself does not reliably measure inflammatory activity, so it must be interpreted alongside other findings.

Quality of life: Doctors assess how UC symptoms influence a person’s diet, sleep, work, physical activity, social life, and emotional health.

Physical examination: Healthcare professionals may assess general appearance, hydration, temperature, pulse, blood pressure, abdominal tenderness, distension, and other signs of systemic illness. Severe inflammation can be associated with systemic abnormalities.

Inflammatory markers: Blood tests such as C-reactive protein (CRP) and ESR can provide evidence of systemic inflammation. Other tests may assess anemia, nutritional status, and complications. These tests support, but do not replace, clinical and endoscopic assessment.

Stool inflammatory markers: Tests such as fecal calprotectin can provide noninvasive information about intestinal inflammation and can be useful when monitoring disease activity.

Endoscopy: Colonoscopy or flexible sigmoidoscopy enables doctors to directly examine the inner lining of the colon and identify signs of inflammation, bleeding, ulcers, or other abnormalities. Endoscopic evaluation is valuable because the severity of intestinal inflammation may not always correspond closely with the patient’s symptoms.

Change over time: Doctors compare current findings with previous visits. Improvement in bleeding, stool frequency, inflammatory markers, or endoscopic findings may indicate treatment response, while worsening findings may indicate a flare or inadequate disease control.

How these findings are interpreted

The overall picture helps clinicians describe UC activity as mild, moderate, or severe, depending on the clinical situation and scoring system being used. There is no single symptom, blood test, or endoscopic finding that should always be used alone to determine overall disease severity.

Why Is Measuring Disease Activity Important?

Measuring disease activity is important because UC is a chronic inflammatory disease that can change over time. A patient may have periods of active disease and periods of remission. Regular assessment helps clinicians determine whether inflammation is adequately controlled and whether treatment is achieving its intended goals.

Establishing a baseline

When UC is first diagnosed, doctors establish a baseline assessment. This may include symptoms, stool frequency, bleeding, blood tests, stool inflammatory markers, endoscopy, and disease extent.

A baseline establishes a starting point that doctors can use to compare disease activity during future assessments.

Example:

If a patient initially has frequent bloody stools and severe endoscopic inflammation, later assessments can determine how much these findings have improved.

Determining the severity of a flare

During a flare, disease-activity assessment helps determine whether the episode appears mild, moderate, or severe.

Doctors may evaluate:

Number of stools
Amount of rectal bleeding
Fever
Heart rate
Abdominal findings
Hemoglobin
Inflammatory markers
Endoscopic severity

This is particularly important when severe UC or acute severe ulcerative colitis is suspected.

Monitoring response to treatment

After treatment begins, doctors need to determine whether it is working.

Improvement may include:

Fewer bowel movements
Less rectal bleeding
Reduced urgency
Better daily functioning
Falling inflammatory markers
Lower fecal calprotectin
Improvement on endoscopy

A treatment response is therefore assessed using multiple indicators rather than simply asking whether the patient feels better.

Identifying persistent inflammation

A patient may report substantial symptom improvement while inflammation remains present in the colon.

This is clinically important because persistent inflammation can indicate incomplete disease control. Studies and reviews emphasize that assessment should consider both clinical symptoms and objective inflammatory findings.

Detecting relapse

Regular monitoring can help detect a relapse, when previously controlled ulcerative colitis becomes active again.

Possible warning signs include:

Increasing stool frequency
Return of rectal bleeding
Increasing urgency
Abdominal symptoms
Rising inflammatory markers
Increasing fecal calprotectin

Early recognition allows the healthcare team to investigate the cause and determine appropriate management.

Assessing remission

The aim of treatment is not merely to provide temporary symptom relief but to achieve sustained disease control and reduce underlying intestinal inflammation. Doctors may assess whether the patient has reached clinical remission and whether objective inflammation has also improved.

The evaluation may involve symptoms, inflammatory biomarkers, and endoscopic healing, depending on the specific goals of treatment.

Planning follow-up

Disease activity helps determine how closely a patient needs to be monitored.

Patients with persistent symptoms, elevated inflammatory markers, or significant endoscopic inflammation may require closer follow-up than patients with stable disease control.

Comparing disease activity over time

Repeated measurements allow doctors to see the direction of the disease:

Active disease → treatment → improvement → remission

Remission → increasing symptoms/inflammation → relapse

This longitudinal comparison can be more informative than a single assessment.

Supporting treatment decisions

Disease-activity information helps clinicians decide whether to:

Continue the current treatment
Optimize treatment
Investigate another cause of symptoms
Change therapy
Escalate treatment
Perform additional investigations
Consider specialist or hospital-based management when appropriate

Treatment plans should be tailored to each patient based on their symptoms, disease activity, test results, and overall clinical condition.

Symptoms Used to Assess Disease Activity

Symptoms provide an important first indication of how active UC may be.

Increased stool frequency

Patients with active UC may pass stools more frequently than usual. The number of bowel movements per day is therefore an important component of several disease-activity assessments.

Rectal bleeding

Rectal bleeding is a common and important indicator of active ulcerative colitis. The amount and frequency of bleeding can provide information about disease activity.

Urgency

Some people experience a sudden, urgent need to pass stool that can be difficult to postpone. Severe urgency may significantly interfere with work, travel, sleep, and normal daily activities.

Nocturnal bowel movements

Having to wake during the night to pass stool can indicate significant bowel disturbance and is incorporated into some clinical scoring systems.

Abdominal discomfort

Abdominal cramps or discomfort may occur in ulcerative colitis, but these symptoms should be evaluated alongside objective measures of intestinal inflammation.

Fatigue

Inflammation, anemia, poor sleep, nutritional problems, and the general burden of chronic disease can contribute to fatigue.

Clinical Examination

A physical examination provides additional information beyond the patient's symptoms. Healthcare professionals may assess vital signs, general appearance, hydration, abdominal tenderness, abdominal distension, and other findings. Physical examination generally uses inspection, palpation, percussion, and auscultation.

In a severe UC flare, doctors may pay particular attention to:

Fever
Rapid heart rate
Low blood pressure
Dehydration
Abdominal tenderness
Abdominal distension
Significant weakness
Signs of anemia
Reduced general condition

These findings can help determine whether urgent assessment or hospitalization is necessary.

Blood Tests

Blood tests cannot independently prove how active UC is, but they provide useful supporting information.

Common tests include:

Complete blood count (CBC):

May identify anemia or changes in white blood cells and platelets.

C-reactive protein (CRP):

CRP is an inflammatory marker that may increase when systemic inflammation is present.

Erythrocyte sedimentation rate (ESR):

ESR is another marker that can support assessment of inflammatory activity.

Electrolytes and kidney function:

These can help identify dehydration or complications, particularly during significant diarrhea.

Albumin:

Low albumin may occur with significant intestinal inflammation or poor nutritional status.

Laboratory testing is most useful when interpreted alongside symptoms, examination, stool testing, and endoscopic findings rather than in isolation.

Stool Tests

Stool testing is especially useful because it can provide information about intestinal inflammation.

Fecal calprotectin (FC) is commonly used as a noninvasive biomarker of intestinal inflammation. It can be useful for monitoring inflammatory activity and response to treatment.

Stool tests may also be used to investigate infections. This is important because infectious diarrhea can resemble a UC flare.

Therefore, when symptoms suddenly worsen, clinicians may consider both:

Active UC inflammation
An infectious or other non-IBD cause

The interpretation of fecal calprotectin should be individualized rather than based on one universal number.

Endoscopy and Objective Assessment

Endoscopy is an important component of evaluating UC because it allows the clinician to directly examine the intestinal lining.

Colonoscopy or flexible sigmoidoscopy can demonstrate findings such as:

Loss of normal vascular pattern
Redness
Friability
Erosions
Ulcers
Spontaneous bleeding

Endoscopy remains a reference method for evaluating inflammatory activity in UC. Current guidance recommends combining clinical indices with objective assessment rather than depending on symptoms alone.

Mayo Score

The Mayo Clinic Score, commonly called the Mayo Score, is one of the best-known scoring systems used in UC.

It combines several areas of assessment, including:

Stool frequency
Rectal bleeding
Endoscopic findings
Physician's global assessment

Each component is scored from 0 to 3, with higher scores generally indicating greater disease activity.

The Mayo system is widely used in clinical trials and clinical practice. Its endoscopic component is particularly important when assessing mucosal inflammation.

Partial Mayo Score

The Partial Mayo Score is a version of the Mayo system that does not require the endoscopic component.

It can therefore be useful during routine follow-up when repeated endoscopy is not appropriate or necessary.

It primarily reflects clinical disease activity and can help clinicians follow whether symptoms are improving or worsening.

However, a low symptom score does not necessarily prove that the intestinal lining has completely healed.

Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

The UCEIS is an endoscopic scoring system specifically designed to standardize the assessment of inflammation seen during endoscopy.

It evaluates three major features:

Vascular pattern
Bleeding
Erosions and ulcers

The UCEIS score ranges from 0 to 8, with higher values indicating more severe endoscopic inflammation.

UCEIS is useful because it provides a more structured way of describing what the endoscopist sees.

Simple Clinical Colitis Activity Index

The Simple Clinical Colitis Activity Index (SCCAI) is another clinical scoring system for UC.

It considers symptoms such as:

Daytime stool frequency
Night-time stool frequency
Urgency
Blood in stool
General well-being
Extraintestinal manifestations

It is a practical clinical tool and does not require endoscopy for every assessment.

Truelove and Witts Classification

The Truelove and Witts classification is a traditional approach for describing UC severity, particularly in the context of acute severe disease.

It considers factors such as:

Number of bloody stools
Pulse rate
Temperature
Hemoglobin
ESR or inflammatory markers

It can help clinicians recognize patients with potentially severe disease who may require urgent medical treatment.

Clinical Remission Does Not Always Mean Complete Healing

One of the most important concepts in modern UC management is that feeling better and having completely healed intestinal tissue are not necessarily the same thing.

A patient may have:

Few or no symptoms → but continuing microscopic or endoscopic inflammation.

For this reason, doctors may combine:

Symptoms + clinical score + CRP + fecal calprotectin + endoscopy + histology

to understand the depth of disease control.

STRIDE-II emphasizes clinical remission and endoscopic healing as important targets, while histological healing may provide additional information about the depth of remission.

Treatment Monitoring

Disease activity assessment should continue after treatment begins.

Doctors may monitor:

Short term

Stool frequency
Rectal bleeding
Urgency
General well-being

Intermediate term

CRP
Fecal calprotectin
Clinical remission

Long term

Endoscopic healing
Quality of life
Functional recovery
Sustained disease control

This approach allows treatment to be evaluated using objective evidence rather than symptoms alone.